secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001510964-23-000026
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences shareholders approve 2023 Equity Incentive Plan, elect directors
----------------------------------------------------------------------------

- Stockholders approved 2023 Equity Incentive Plan (11.7M for, 8.6M against) to replace 2013 Plan.
- Elected directors: Dr. Jamie Corroon, Joseph Dowling, Bill McCorkle to serve until next annual meeting.
- Ratified Haskell & White LLP as independent auditor for FY2023 (74.7M for, 1.2M against).
- Non-binding advisory vote on named executive officer compensation approved (11.8M for, 8.7M against).
- Quorum of 50.4% (76.6M of 152.1M shares) present at virtual annual meeting on June 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096423000026/0001510964-23-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096423000026/cvsi-20230601.htm
  HTML page:      https://secwatch.observer/filing/0001510964-23-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer